• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Circle Cardiovascular Imaging Announces Partnership with Dia Imaging Analysis to Deliver All-in-one Comprehensive Ai-based Cardiovascular Imaging Solutions

Share:

June 15, 2021

Today, Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. are excited to announce a multi-year partnership that leverages the companies’ synergies in cardiac AI and data analytics.

As a global leader in cardiovascular imaging reading and reporting for Cardiac MR and Cardiac CT, Circle CVI has now expanded its rich product offering to a complete cardiovascular imaging portfolio, with the addition of DiA’s FDA-cleared and CE-marked LVivo™ Toolbox – a line of innovative AI-based cardiac ultrasound solutions. This collaboration will deliver expanded state-of-the-art multi-modality imaging solutions to Circle CVI’s customers while providing new opportunities for physicians, patients, and hospitals worldwide.

“By adding DiA’s solutions, Circle CVI is broadening its extensive portfolio of cardiovascular MR and CT, to include ultrasound imaging functionality, offerings that are unparalleled in the market,” said Greg Ogrodnick, CEO of Circle Cardiovascular Imaging.

Circle CVI will offer its customers DiA’s LVivo Toolbox, a set of cardiac ultrasound AI solutions which will include LVivo Seamless™ – a unique system that runs “behind the scenes,” automatically selecting the optimal cardiac ultrasound views and generating automated quantifications and indications of both left and right ventricles. The system then immediately extracts these results to the echo reports.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The solutions of both companies are vendor-neutral, running on any scanner, and they can easily integrate into hospital and enterprise sites, with deployments that work with any IT infrastructure.

“Joining forces with Circle CVI will accelerate our mission to rapidly deploy health providers with our most advanced and most accurate cardiac ultrasound AI solutions, which will simplify workflows and improve patient outcomes,” said Hila Goldman-Aslan, CEO of DiA Imaging Analysis.

DiA will spotlight its AI-enabled solutions across its imaging portfolio at the upcoming American Society of Echocardiography (ASE) 2021 virtual event (June 18-21, 2021).

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Minerva Surgical® Announces Acquisition Closing of Boston Scientific Intrauterine Health ProductsMinerva Surgical® Announces Acquisition Closing of Boston Scientific Intrauterine Health Products
  • AbleTo Launches Full Suite of Mental Health Solutions to Address the Great and Growing Demand for CareAbleTo Launches Full Suite of Mental Health Solutions to Address the Great and Growing Demand for Care
  • Aetna Partners with Gastrointestinal Care Company Oshi HealthAetna Partners with Gastrointestinal Care Company Oshi Health
  • Contraceptives Market to Grow at 5.5% CAGR – Global Forecast to 2027Contraceptives Market to Grow at 5.5% CAGR – Global Forecast to 2027
  • Biotechnology and Medicine Startups Top the Innovators Under 35 Europe ListBiotechnology and Medicine Startups Top the Innovators Under 35 Europe List
  • Invitae Sells Reproductive Health Assets to Natera for up to $52.5MInvitae Sells Reproductive Health Assets to Natera for up to $52.5M
  • Global Decentralized Clinical Trial 2021 Insights – Growth Opportunities and Strategic ImperativesGlobal Decentralized Clinical Trial 2021 Insights – Growth Opportunities and Strategic Imperatives
  • ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/ImpaxANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications